We believe that one effective way to accelerate adoption of in silico technologies is to establish a pre-competitive safe space where professionals working in academia, industry, regulators agencies, research hospitals, software houses, and contract research organisations can exchange information and establish best practices.
Community of Practice
The adoption of In Silico Trials is a disruptive change and, like all major changes, it encounters some resistance.
To overcome this resistance, we thought of a safe, pre-competitive space where all experts and practitioners from academia, industry and regulatory agencies can ask for advices, exchange information, develop best practices and discuss anything else that can make the use of In Silico Trials an accepted practice.
The community is configured like a forum where members can join teams and collaboratively work on shared goals, projects, concerns, problems or topics.
The community is invitation-only: in this way we assure that only experts with professional interest in in silico medicine have access to the channels and resources.
The practice of In Silico Trials is still far from being established. Most of the research so far has been conducted in academic laboratories and thus far from the needs of industrial users. This is why our community works to consolidate a set of industrial practices that make easier and reliable the development and use of In Silico Trials solutions.
In Silico World is currently supporting several initiatives in this area:
As our community keeps growing and recently reached 400 members, we felt the need to establish a small governance that reflects and represents its members.
This is why every channel in the community now has an administrator, who is invited to the private channel @Governance, where all admins will discuss and take decisions for the life of the community.
